ALDH1A1 and head and neck squamous cell carcinoma: Histopathological analyses seem to corroborate these findings because the increased immunohistochemical levels of ALDH1, CD44, or pSTAT3 were associated with shorter overall survival in HNSCC patients, while the worst survival rate was observed in triple-positive patients (Chen et al. 2010).